Skip to main content
Wanbury Limited logo

Wanbury Limited — Investor Relations & Filings

Ticker · WANBURY ISIN · INE107F01022 LEI · 335800QB384KGMBID276 BSE.NS Manufacturing
Open in API
Filings indexed 912 across all filing types
Latest filing 2025-04-03 Regulatory Filings
Country IN India
Listing BSE.NS WANBURY

About Wanbury Limited

https://www.wanbury.com

Wanbury Limited specializes in the development and manufacture of Active Pharmaceutical Ingredients (APIs) and finished formulations. The organization maintains a significant global presence, particularly as a leading producer of Metformin. Its product portfolio spans diverse therapeutic areas, including gynecology, orthopedics, hematinics, and anti-diabetics. The company operates manufacturing facilities compliant with international regulatory standards, including the USFDA. Wanbury focuses on providing medicinal solutions through integrated research and development capabilities and large-scale production infrastructure, serving both domestic and international markets with a range of specialty products.

Recent filings

Filing Released Lang Actions
Intimation of Improved capacity utilization for Q4 and improved margins
Regulatory Filings
2025-04-03 English
Press Release
Capital/Financing Update Classification · 90% confidence The document is a letter addressed to the National Stock Exchange of India and BSE Limited, dated April 3, 2025. It informs about improved capacity utilization and improved margins for Q4 following a plant upgrade in Q3. It also mentions a plant visit for investors/analysts scheduled for April 10, 2025. The letter references Regulation 30(6) of SEBI (Listing Obligations and Disclosure Requirements) Regulations, which pertains to disclosure of material events. The content is an update on operational performance and a notification of an investor event, not a full financial report or earnings release. The document length is 4624 characters, which is relatively short and reads like an announcement rather than a detailed report. There are no financial statements or detailed financial data included. Therefore, this document is best classified as a Capital/Financing Update (CAP) because it provides an update on operational capacity and margins, which are relevant to investors and relate to company performance improvements and efficiency initiatives, but it is not a full earnings release or annual/interim report.
2025-04-03 English
Intimation of schedule of Investors/ Analysts Plant Visit
Regulatory Filings
2025-04-02 English
Press Release
Regulatory Filings Classification · 95% confidence The document text is extremely short (690 characters) and contains only a digital signature block with no substantive content related to financial performance, management changes, or any specific report. There is no mention of any report type, fiscal period, or regulatory body. The content resembles an officer certification or attestation rather than a full report or announcement. According to the Certification Rule, such documents should be classified as Regulatory Filings (RNS).
2025-04-02 English
The trading window shall be closed from 01st April, 2025 till 48 hours after the declaration of Audited Financial Statements of the Company for the last quarter and year ended 31st March, 2025.
Regulatory Filings
2025-03-27 English
Trading Window
Regulatory Filings Classification · 95% confidence The document text is extremely short (635 characters) and consists solely of a digital signature block with no substantive content related to financial reports, announcements, or filings. There is no mention of any report type, financial data, regulatory body, or corporate event. Given the lack of content and the nature of the text, it does not fit into any specific filing category. According to the rules, such documents that do not neatly fit anywhere else should be classified as Regulatory Filings (RNS).
2025-03-27 English

Browse filings by year

17 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.